why choose us

First received: October 24, 2024

Clinical Trial: A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dry Eye Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 3b Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

Brief Summary: The purpose of this study is to evaluate the proportion of ocular adverse events reported in subjects with dry eye disease (DED) between the intervention arm (0.003% AR-15512) and Refresh® Classic.

Read more